UNSPSC 51143004: Amifampridine

This classification denotes a cation channel blocker with the molecular formula C5H7N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RU4S6E2G0J, chemically known as 3,4 DIAMINOPYRIDINE, but generally known as amifampridine. European Medicines Agency schedules amifampridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB28846. As of Q4 2014, AMIFAMPRIDINE remains the US FDA Preferred Term for this commodity. Amifampridine bears US NLM identifiers UMLS ID C0046948 and NCI Concept Code C82687.

SMILES: none.

UNSPSC 51143004 Amifampridine is a Commodity code tracking state and local procurement of this potassium-channel blocker pharmaceutical, used primarily to treat myasthenia gravis and Lambert-Eaton myasthenic syndrome. State and local governments procure amifampridine through Medicaid agencies, state health departments, corrections departments, and public hospital systems to supply patients in their care — including institutionalized populations, outpatient clinics, and pharmacy benefit programs. The drug is purchased as a finished pharmaceutical product, typically under contract or standing order with pharmaceutical wholesalers or manufacturers.

The source contains no recent state and local contract opportunities tagged to this code.